Home

ELAN CORP PLC

CIK 737572 · last filed 2014-02-04

ELAN CORP PLC is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2014. The most recent filing shows the insider sold $238.3M of PRTA on Feb 4, 2014. Across all open-market trades the lifetime net is −$238.3M, making them a net seller over the disclosed history. The firm reports its address in Dublin 2, L2. 15 SEC filings were submitted jointly with DOV PHARMACEUTICAL INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

1

Lifetime Open-Market Net

-$238.29M

Filer Profile

Reported Address
TREASURY BUILDING
LOWER GRAND CANAL STREET
DUBLIN 2, L2 00000
Phone
35317094000
Related Filers
DOV PHARMACEUTICAL INC — 15 joint filings, latest 2004-09-09
LIGAND PHARMACEUTICALS INC — 12 joint filings, latest 2003-07-22
ELAN PHARMA INTERNATIONAL LTD. — 11 joint filings, latest 2013-08-02
CAPITAL RESEARCH & MANAGEMENT CO — 6 joint filings, latest 2005-04-08
RP Management, LLC — 6 joint filings, latest 2013-04-15
& JOHNSON JOHNSON — 3 joint filings, latest 2013-06-13
ARDSLEY ADVISORY PARTNERS LP — 2 joint filings, latest 1997-02-10
Shane Cooke — 2 joint filings, latest 2011-11-04
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PRTA 10%+ Owner 0 $8.93 $0 -$238.29M 1 2014-02-04

Recent Filings

1 filing
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2014-02-04 PRTA Sell (S) −9,546,759 -$238.29M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.